FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
7,994 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Doxepin Hydrochloride | Doxepin hydrochloride 75 mg/1 | CapsuleOral | First Nation Group, LLC | ANDA | 81469-418 | 81469-0418-0181469-0418-05 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 100 mg/1 | CapsuleOral | First Nation Group, LLC | ANDA | 81469-419 | 81469-0419-0181469-0419-05 | — |
| Doxepin hydrochloride | Doxepin hydrochloride 25 mg/1 | CapsuleOral | Proficient Rx LP | ANDA | 82804-011 | 82804-0011-3082804-0011-6082804-0011-90 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 10 mg/1 | CapsuleOral |
| Proficient Rx LP |
| ANDA |
| 82804-305 |
| 82804-0305-30 |
| — |
| Doxepin Hydrochloride | Doxepin hydrochloride 10 mg/1 | CapsuleOral | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | ANDA | 83209-424 | 83209-0424-30 | — |
|---|
| Doxepin Hydrochloride | Doxepin hydrochloride 25 mg/1 | CapsuleOral | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | ANDA | 83209-638 | 83209-0638-30 | — |
|---|
| Doxercalciferol | Doxercalciferol .5 ug/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | 23155-538 | 23155-0538-25 | — |
|---|
| Doxercalciferol | Doxercalciferol 1 ug/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | 23155-539 | 23155-0539-25 | — |
|---|
| Doxercalciferol | Doxercalciferol 2.5 ug/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | 23155-540 | 23155-0540-25 | — |
|---|
| Doxercalciferol | Doxercalciferol 4 ug/2mL | InjectionIntravenous | Dr.Reddy's Laboratories Inc | ANDA | 43598-850 | 43598-0850-50 | — |
|---|
| Doxercalciferol | Doxercalciferol 2 ug/mL | Injection, SolutionIntravenous | Eugia US LLC | ANDA | 55150-357 | 55150-0357-50 | — |
|---|
| Doxercalciferol | Doxercalciferol 4 ug/2mL | Injection, SolutionIntravenous | Eugia US LLC | ANDA | 55150-358 | 55150-0358-50 | — |
|---|
| Doxercalciferol | Doxercalciferol 4 ug/2mL | Injection, SolutionIntravenous | Eugia US LLC | ANDA | 55150-359 | 55150-0359-50 | — |
|---|
| Doxercalciferol | Doxercalciferol .5 ug/1 | CapsuleOral | Chartwell RX, LLC | ANDA | 62135-450 | 62135-0450-30 | — |
|---|
| Doxercalciferol | Doxercalciferol 1 ug/1 | CapsuleOral | Chartwell RX, LLC | ANDA | 62135-451 | 62135-0451-30 | — |
|---|
| Doxercalciferol | Doxercalciferol 2.5 ug/1 | CapsuleOral | Chartwell RX, LLC | ANDA | 62135-452 | 62135-0452-30 | — |
|---|
| Doxercalciferol | Doxercalciferol 4 ug/2mL | Injection, SolutionIntravenous | Alembic Pharmaceuticals Inc. | ANDA | 62332-690 | 62332-0690-3062332-0690-50 | — |
|---|
| Doxercalciferol | Doxercalciferol 4 ug/2mL | Injection, SolutionIntravenous | Gland Pharma Limited | ANDA | 68083-300 | 68083-0300-50 | — |
|---|
| Doxercalciferol | Doxercalciferol 4 ug/2mL | Injection, SolutionIntravenous | Gland Pharma Limited | ANDA | 68083-359 | 68083-0359-50 | — |
|---|
| Doxercalciferol | Doxercalciferol .5 ug/1 | CapsuleOral | REMEDYREPACK INC. | ANDA | 70518-4642 | 70518-4642-0070518-4642-02 | — |
|---|
| Doxercalciferol | Doxercalciferol 4 ug/2mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | ANDA | 71288-802 | 71288-0802-04 | — |
|---|
| Doxildoxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Suspension, LiposomalIntravenous | Baxter Healthcare Company | NDA | 0338-0063 | 00338-0063-01 | — |
|---|
| Doxildoxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Suspension, LiposomalIntravitreal | Baxter Healthcare Company | NDA | 0338-0067 | 00338-0067-01 | — |
|---|
| Doxildoxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Suspension, LiposomalIntravenous | Baxter Healthcare Corporation | NDA | 0338-9665 | 00338-9665-01 | — |
|---|
| Doxildoxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Suspension, LiposomalIntravenous | Baxter Healthcare Corporation | NDA | 0338-9667 | 00338-9667-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-0255 | 00069-0255-10 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-0277 | 00069-0277-02 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-0343 | 00069-0343-02 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-0358 | 00069-0358-20 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-1442 | 00069-1442-04 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-1542 | 00069-1542-20 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-3358 | 00069-3358-25 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-4031 | 00069-4031-12 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-4205 | 00069-4205-05 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | NDA | 0069-5629 | 00069-5629-05 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9084 | 00143-9084-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9085 | 00143-9085-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9086 | 00143-9086-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9087 | 00143-9087-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9088 | 00143-9088-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9089 | 00143-9089-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9090 | 00143-9090-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9091 | 00143-9091-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9092 | 00143-9092-01 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | Hikma Pharmaceuticals USA Inc. | ANDA | 0143-9093 | 00143-9093-01 | — |
|---|
| doxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Sagent Pharmaceuticals | ANDA | 25021-207 | 25021-0207-2525021-0207-51 | — |
|---|
| Doxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | Actavis Pharma, Inc. | ANDA | 45963-733 | 45963-0733-5545963-0733-5745963-0733-60+1 more | — |
|---|
| doxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Suspension, LiposomalIntravenous | Alembic Pharmaceuticals Limited | ANDA | 46708-525 | 46708-0525-25 | — |
|---|
| doxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Suspension, LiposomalIntravenous | Alembic Pharmaceuticals Limited | ANDA | 46708-810 | 46708-0810-10 | — |
|---|
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | Sun Pharmaceutical Industries, Inc. | ANDA | 47335-049 | 47335-0049-40 | — |
|---|